• Site Search
  • Lawyer Search

Life Sciences

  • Print PDF
  • Subscribe to RSS
  • MoFolder
MoFo BioMeter
Stephen Thau and Anelia Delcheva
8/28/2013
Emerging Companies + Venture Capital, Life Sciences
Newsletter
A Victory for Generics Suppliers
Chain Drug Review
Erin Bosman, James Huston, Julie Park, and Joanna Simon
8/5/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Q&A With Morrison & Foerster's Michael Ward
Law360
Michael Ward
7/8/2013
Clean Technology + Alternative Energy, Interferences, IP Due Diligence, Life Sciences, Patent Counseling + Prosecution, Patent Reexaminations
Article
Reprinted with permission.
Mutual v. Bartlett Further Shields Generic Drug Manufacturers from Liability
James Huston, Erin Bosman, Julie Park, and Joanna Simon
6/24/2013
Life Sciences, Litigation, Trials + Appeals, Pharmaceutical + Medical Device, Product Liability
Client Alert
Supreme Court Holds that "Reverse Payment" Patent Settlements are Subject to Potential Antitrust Condemnation, but only After Full-Blown Rule of Reason Review
David Meyer and Robert Nichols
6/18/2013
Antitrust Law, Antitrust Law | Litigation, Appellate + Supreme Court, Life Sciences
Client Alert
No More Isolated DNA Patents, the Supreme Court Rules
James Mullen and Mary Prendergast
6/13/2013
Appellate + Supreme Court, Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
When In Doubt, Write Your Doctor A Letter
Law360
James Huston, Ellen Adler, and Joanna Simon
6/7/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Dey, L.P. v. Sunovion Pharmaceuticals, Inc., No. 2012-1428
The Federal Circuit Bar Association Case Digest, Vol. 16, No. 12
Kristin Yohannan and Andrea Contreras
June 2013
Life Sciences, Patent and Trademark Office Trial Group
Article
FDA Letter to Mobile App Developer Signals Regulatory Scheme
Erin Bosman, Aramide Fields, and Julie Park
5/31/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Other Transactional Authority: A Nontraditional Tool for Partnering with the Federal Government
Bradley Wine and Tina Reynolds
5/29/2013
Government Contracts, Life Sciences
Client Alert
MoFo Biometer
Volume 2, Issue 2
Stephen Thau and Anelia Delcheva
5/22/2013
Emerging Companies + Venture Capital, Life Sciences
Newsletter
Jury Buys Plaintiff’s Argument That Drug Manufacturer Should Have Distributed Dear Doctor Letter Sooner, Without Prior FDA Approval
James Huston, Ellen Adler, and Joanna Simon
5/15/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Bowman v. Monsanto: Crisis Averted on IP Protection for Self-Replicating Technologies
Matthew Chivvis, Matthew Kreeger, and Michael Ward
5/14/2013
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules
Marc Hearron, James Mullen, and Matthew Kreeger
4/15/2013
Appellate + Supreme Court, Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Mind the gap: Sixth Circuit finds room for suit against generics after Mensing
International Law Office
James Huston, Erin Bosman, Julie Park, and Jeffrey David
4/9/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
The AIA Technical Corrections Act Changes How Patent Term Adjustment is Calculated and Challenged
Janet Xiao and Alexandra Cavazos
4/9/2013
Intellectual Property Litigation, Interferences, Life Sciences, Patent Counseling + Prosecution, Patent Litigation, Patent Reexaminations
Client Alert
A Narrow Exception To The Mensing Preemption Defense
Law360
James Huston, Erin Bosman, Julie Park, and Jeffrey David
4/4/2013
Appellate + Supreme Court, Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Driving on both sides of the road: Supreme Court hears Bartlett oral argument
International Law Office
James Huston, Erin Bosman, Julie Park, and Joanna Simon
4/2/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Breaking Down The Bartlett Oral Argument
Life Sciences Law360
James Huston, Erin Bosman, Julie Park, and Joanna Simon
4/1/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Reprinted with permission.
Howard v. Zimmer: Negligence Per Se Based on Violations of the FDCA—Blurring the Line Between Parallel Claims and Preemption
James Huston, Erin Bosman, and Joanna Simon
3/27/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Driving on Both Sides of the Road: Supreme Court Hears Bartlett Oral Argument
James Huston, Erin Bosman, Julie Park, and Joanna Simon
3/20/2013
Appellate + Supreme Court, Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Mind the Gap: Sixth Circuit Finds Room for Suit Against Generic Manufacturers After Mensing
James Huston, Erin Bosman, Julie Park, and Jeffrey David
3/14/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
MoFo Biometer
Volume 2, Issue 1
Stephen Thau and Anelia Delcheva
2/25/2013
Emerging Companies + Venture Capital, Life Sciences
Newsletter
America Invents Act: USPTO Publishes Final Examination Guidelines for the First-Inventor-to-File Provisions
Randy Omid and Otis Littlefield
2/19/2013
Intellectual Property Litigation, Interferences, IP Due Diligence, Life Sciences, Patent Counseling + Prosecution, Patent Litigation, Patent Reexaminations
Client Alert
Australian Federal Court Upholds Myriad’s Gene Patent
James Mullen and Mary Prendergast
2/15/2013
Intellectual Property, Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution
Client Alert
Weeks defies years of jurisprudence, allowing innovator liability for generic drugs
International Law Office
James Huston, Erin Bosman, and Julie Park
2/12/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Wyeth v. Weeks: Implications for Pharma Manufacturers
Law360
James Huston, Erin Bosman, and Julie Park
2/6/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Beineke v. Kappos - Are Discovered Plants Patentable?
Matthew Chivvis, Rachel Krevans, and Michael Ward
1/28/2013
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Generic Drug Liability Ruling Raises Concerns
Business Insurance
Erin Bosman and James Huston
1/28/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Anticipating First-to-File: What to do to Prepare for the United States Patent System’s Change to First-to-File
Otis Littlefield
1/23/2013
Intellectual Property Litigation, Interferences, IP Due Diligence, Life Sciences, Patent Counseling + Prosecution, Patent Litigation, Patent Reexaminations
Client Alert
The Broad Reach Of New 'Failure-To-Warn-FDA' Claims
Law360
Erin Bosman, Joanna Simon, and Julie Park
1/23/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Weeks Defies Years of Jurisprudence, Allowing Innovator Liability for Generic Drugs
James Huston, Erin Bosman, and Julie Park
1/17/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
China Life Sciences Newsletter
中国生命科学通讯
Gabriel Bloch, Peng Chen, Thomas Chou, Gordon Milner, and Kun Wang
1/16/2013
China, Corporate, Intellectual Property, Life Sciences, Technology Transactions
Newsletter
Stengel Tangles MDA Preemption:
Ninth Circuit Decision Creates Split on Buckman Preemption of Post-Market Reporting Requirements
Erin Bosman, Joanna Simon, and Julie Park
1/14/2013
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
MoFo BioMeter
Stephen Thau, Anelia Delcheva, Van Ellis, Gabriel Meister, Julian Thurston, and Mark Wicker
12/12/2012
Emerging Companies + Venture Capital, Life Sciences
Newsletter
Second Circuit Delivers Blow to Off-Label Promotion Prosecutions in U.S. v. Caronia
Adam Hoffinger, Robert Salerno, and Demme Doufekias
12/5/2012
Health Care Fraud – Investigations + Litigation, Life Sciences, Pharmaceutical + Medical Device, White-Collar Defense
Client Alert
Supreme Court to Hear Design Defect Preemption Case
James Huston, Erin Bosman, and Julie Park
12/3/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Client Alert
Myriad Finally Gets Its Day in (the Supreme) Court
James Mullen and Mary Prendergast
11/30/2012
Appellate + Supreme Court, Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Sound the Alarm?—The Supreme Court’s Renewed Interest in Life Sciences Patents Could Create Additional Hurdles Across the Field
Matthew Chivvis, Rachel Krevans, and Michael Ward
11/16/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
District Court Decision Opens Door to Additional Patent Term Adjustment
Janet Xiao
11/14/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Physician Payment Sunshine Act: Challenge for Companies, Tool for Enforcers
Adam Hoffinger, Robert Salerno, and Demme Doufekias
10/19/2012
Health Care Fraud – Investigations + Litigation, Life Sciences, Pharmaceutical + Medical Device, White-Collar Defense
Client Alert
Patent Exhaustion and Self-Replicating Technologies
The Solicitor General Asks the Supreme Court to Decline Review in Bowman v. Monsanto
Matthew Chivvis, Michael Ward, and Rachel Krevans
9/5/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Judges Don't Budge in Myriad:
Federal Circuit Again Finds Isolated Gene Sequences are Patent-Eligible Subject Matter
James Mullen and Mary Prendergast
8/16/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Client Alert
Fast and Furious (Toward Patents): USPTO Issues Final Post-Grant Rules
Mehran Arjomand and Stephen Jones
8/15/2012
Intellectual Property Litigation, Interferences, IP Due Diligence, Life Sciences, Patent Counseling + Prosecution, Patent Litigation, Patent Reexaminations
Client Alert
USPTO Issues Interim Guidance for Subject Matter Eligibility in the Wake of Prometheus
Janet Xiao and Matthew Show
7/10/2012
Intellectual Property Litigation, Life Sciences, Patent Litigation
Client Alert
The Patent Office Knows the Way to San Jose (and Denver and Dallas)
Brian Ho and Michael Ward
7/3/2012
Life Sciences, Patent Counseling + Prosecution
Client Alert
Intellectual Property Quarterly Newsletter
Summer 2012
Eric Acker, Brian Donahue, Cary Miller, Gladys Monroy, Terri Shieh-Newton, and Matthew Show
6/28/2012
Intellectual Property Litigation, Life Sciences, Patent Counseling + Prosecution, Patent Litigation
Newsletter
Pathway for Follow-on Biologics Survives the Supreme Court
Amy Mills and Cary Miller
6/28/2012
Life Sciences
Client Alert
FDA Bone Drug Study Offers New Pathway For Plaintiffs
Product Liability Law360
James Huston
5/10/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
Implications — And Complications — Of Undoing Mensing
Law360
James Huston, Erin Bosman, and Julie Park
5/7/2012
Life Sciences, Pharmaceutical + Medical Device, Product Liability
Article
View All
This is MoFo.
Share
© 1996-2013 Morrison & Foerster LLP. All rights reserved.
[ A- | A+ ]
Loading...
Loading...